All posts by imreal

Global Wellness Summit Announces Groundbreaking “Call for Innovation” Competition


News Image

The focus on health and wellness in the metaverse is timely: It’s already a key aspect of the emerging metaverse and it’s going to make even more of an impact in the next few years

The Global Wellness Summit (GWS), the most prestigious conference on the $4.4 trillion business of wellness, today announced the focus of its 3rd annual Call for Innovation competition: Wellness and the Metaverse. This is the first global competition for startups and established companies now creating health and wellness solutions and experiences for the emerging metaverse and Web3.

Submissions will be judged by a heavy-hitter group of ten international CEOs, business leaders and venture capitalists in the wellness and tech spaces. These include two top executives in charge of tech startups and wellbeing at Meta, the head of the Technological Infrastructure Division at the Israeli Innovation Institute, and the Head of Strategy at Nike Data Science Innovation. The “Global Wellness Summit Prize” will be awarded at the conference being held at the Hilton Tel Aviv from October 31 to November 3.

The Call for Innovation was founded in 2020 by the GWS and WellTech Ventures, Israel’s leading fund focused exclusively on investing in the wellness space. WellTech Ventures has sponsored the competition since 2020, and this year they’re spearheading the competition in addition to being host sponsor of the Tel Aviv Summit. The GWS, and Meta (formerly Facebook), the global multinational whose technologies help more than three billion people connect, find communities, and grow businesses, are also sponsors.

“It’s our pleasure to lead another GWS Call for Innovation this year together with Meta,” said Amir Alroy, co-founder of WellTech Ventures. “The focus on health and wellness in the metaverse is timely: It’s already a key aspect of the emerging metaverse and it’s going to make even more of an impact in the next few years because it enables a whole new patient experience and a much more immersive approach to health and wellness.”

“We’re excited to partner with WellTech Ventures and the Global Wellness Summit for this Call for Innovation,” said Omer Rosenblum, Head of Wellbeing Vertical at Meta. “The last few years have sharpened our focus on our health and our wellbeing. We are seeing digital health and wellness at the forefront of innovation and becoming one of the leading sectors of the metaverse–with fitness, mental health and mindfulness startups utilizing XR capabilities to deliver impact to users. This is just the beginning and we’re excited to see what lies ahead for the wellness industry.”

The ‘Why’ of the Competition & How It Works:

The metaverse, a profound digital platform shift, is becoming the multi-trillion-dollar frontier for a more engaged virtual world. A recent report from McKinsey & Co. forecast that annual consumer and business global spending within the metaverse could reach $5 trillion by 2030. Health and wellness will be one of the metaverse’s bright spots, with emerging technologies such as virtual, augmented and merged reality, haptics, blockchain, gamification, and crypto (together with many still unrealized technologies and behaviors) that will better engage more and more people in health and wellness experiences.

Every sector in the global wellness economy–whether it’s fitness, travel, beauty, mental wellness, medical-wellness, nutrition, or employee wellness–has a huge opportunity in the coming metaverse. The competition encourages companies that are innovating new metaverse and Web3 solutions in any wellness sector to apply–from early-stage startups to large, established companies. The winner will have

the opportunity to present their concept to the hundreds of global industry leaders gathered at the Summit.

The contest is now open and closes Sept. 20, 2022. APPLY HERE.

Call for Innovation Winners Are Already Achieving Great Things:

The GWS launched the Call for Innovation competition in 2020, and the first winner, Ilan Samish and his company Amai Proteins, are now disrupting the food industry with their protein-based sugar substitute, a brilliant new weapon in fighting the metabolic health crisis. Amai Proteins recently won the 2022 Extreme Tech Challenge, the largest global competition for entrepreneurs addressing global challenges, where tech legend Bill Gates delivered the keynote at the global finals. Samish will keynote at the 2022 GWS on their next moves in inventing a healthier future for food.

A Powerful Lineup of Judges:

Amir Alroy, co-founder of Welltech Ventures, the Israeli fund building impactful startups in the wellness space, and co-chair of this year’s Global Wellness Summit in Israel.

Galit Horovitz, co-founder of Welltech Ventures, who has extensive experience in business development and international M&A, working with technology, finance and consulting companies.

Nir Orren, Group Director of tech and startups at Meta in Israel, leading a team that supports startups at all stages, and helps them scale.

Omer Rosenblum, Client Partner and head of the Wellbeing Vertical at Meta in Israel, who leads business growth, marketing and strategy for a wide variety of companies in fitness and sports tech, nutrition, mental health, lifestyle, mindfulness, and more.

Aviv Zeevi, VP and head of the Technological Infrastructure Division at the Israel Innovation Institute, where he is responsible for generating collaborations between industry and academia to create advanced technologies and innovative products.

Anthony Diaz, founder & CEO of Passion for Health, who has over a decade of leadership experience in healthcare, global product and platform development, and digital consumer engagement.

Judith Halioua, head of strategy at Nike Data Science Innovation and the liaison between the Israeli startup ecosystem and Nike in Israel.

Mia Kyricos, president and chief love officer (CEO) of Kyricos & Associates, LLC, with twenty years of experience advising wellness, travel/hospitality and healthy lifestyle brands across 100+ countries. She is also founding chair of the Global Wellness Institute’s new Web 3.0 Initiative.

Frank Pitsikalis, VP of strategy for Agilysys, a leading provider of enterprise software for the hospitality industry and founder and former CEO of the recently-acquired ResortSuite, the world’s first software built specifically for wellness-driven hotel, resort, spa, golf and club operations.

Dean Rubin, CTO of the metaverse wellness center Yoga Bulldogz, a backend engineer who manages multiple development teams worldwide. He is a Web3 expert who has contributed to projects like HawsHouse, Okashi, Green Farm Factory and Toyota Dream Car.

“This competition has become a signature element of every Summit and I’m deeply grateful to Welltech Ventures for their continued support, and delighted to welcome Meta as a sponsor this year,” said Nancy Davis, GWS chief creative officer and executive director. “The pandemic has spurred the wellness industry to be less tech-averse and our organization wants to drive early innovation in what promises to be a fascinating intersection between wellness and the metaverse.”

Registration for the 2022 Summit is open.

About the Global Wellness Summit

The Global Wellness Summit is the premier organization that brings together leaders and visionaries to positively shape the future of the $4.4 trillion global wellness economy. Its future-focused conference is held at a different global location each year and has traveled to the United States, Switzerland, Turkey, Bali, India, Morocco, Mexico, Austria, Italy and Singapore. GWS also hosts other virtual and in-person gatherings, including Wellness Master Classes, Wellness Sector Spotlights, Investor “Reverse Pitch” events and Global Wellness Symposiums. The organization’s annual Global Wellness Trends Report offers expert-based predictions on the future of wellness. The 2022 Summit will be held in Tel Aviv, Israel from October 31 to November 3.

InfraScan Inc. Announces Publication of the Largest Study to date for TBI Diagnosis Utilizing NIRD


InfraScan, a medical device firm specializing in traumatic brain injury diagnostic products, announced the publication of the largest U.S. study to date using a near-infrared device (NIRD) to detect bleeds resulting from Traumatic Brain Injuries (TBI). This independent study was published in the Journal of Neurotrauma on 2 Aug 2022. https://doi.org/10.1089/neu.2021.0342.

“We wish to thank Dr. Michael Haglund, Dr. Anthony Fuller, Dr. Robert Gramer, and the entire team at Duke Global Neurosurgery and Neurology for their superb work in TBI clinical research using near-infrared technology”, said Baruch Ben Dor, PhD, president, and CEO of InfraScan.

The Infrascanner is a portable, hand-held device that uses NIR technology to screen patients for intracranial bleeding, identifying those who would most benefit from neurosurgical intervention and may inform neurosurgical decision-making in settings where CT scanning is unavailable or impractical.

In addition to being independent, this is the largest U.S.-based Infrascanner study published to date with 500 TBI patients, including 104 of these with intracranial bleeds. For all bleeds, the Infrascanner demonstrated 86% sensitivity and 96% specificity. Equally as important, for bleeds within the detection capabilities of Infrascanner (bleeds of more than 3.5 mL), the sensitivity was 94% and the specificity 96%. In those patients who required surgical intervention, the device demonstrated 100% sensitivity.

InfraScan has over 1,000 devices deployed in the US and internationally, including with some of the world’s leading neurotrauma and trauma experts. InfraScan also licensed a variety of patents that apply to hemorrhagic and ischemic stroke detection as well as brain hemorrhage monitoring.

About InfraScan, Inc.

InfraScan, Inc. is a medical device company that focuses on developing, commercializing, and distributing portable brain scanners for head injury and stroke assessment based on near-infrared (NIR) technologies. The company has received funding from the U.S. Army Medical Materiel Development Activity, U.S. Marine Corps, Office of Naval Research, BioAdvance, the Biotechnology Greenhouse of Southeastern Pennsylvania, Ben Franklin Technology Partners of Southeastern Pennsylvania, and the Philadelphia Industrial Development Corporation. For more information visit http://www.infrascanner.com and follow us @infrascanner.

Contact: Media

David Clarke

Vice President of Business Development

InfraScan, Inc.

(603) 566-5149

Share article on social media or email:

Serenus Global Inc. is Now A Licensed Controlled Substance Dealer, Licensed by Health Canada


News Image

“From day one, Serenus’ mission had remained focused on cultivating and producing controlled substances with consistent high quality that are safe to use and that will supply our customers with options for new treatments in the areas of depression, PTSD, addiction control and mental health”

Serenus Global Inc. has been granted its first Controlled Substance Dealer’s License by Health Canada. Through its wholly-owned subsidiary Conscious Compounds Inc.., this license allows for the possession, production, sale, transportation, import, export and delivery of Psilocybin and Psilocin within the regulated framework set forth by Health Canada.

“From day one, Serenus’ mission had remained focused on cultivating and producing controlled substances with consistent high quality that are safe to use and that will supply our customers with options for new treatments in the areas of depression, PTSD, addiction control and mental health,” said Dave Auger, Chief Operating Officer of Serenus Global Inc. “We are proud to become an official license holder for psychedelic mushroom production in Canada, and to demonstrate our team’s ability to navigate the regulatory landscape. We look forward to beginning genetic and product development immediately.”

Serenus will now begin operations at its facility in Calgary, AB—a purpose-built, EU GMP-compliant production and research facility. Initially, Serenus will be dedicated to cultivating, extracting, and researching all-natural psilocybin-containing mushrooms and exploring their genetics. The Company’s GMP-compliant facility will also expand its domestic and international reach in controlled substance production and research. Serenus will continue to expand the science and safety of therapeutic psilocybin mushrooms through research, education and clinical trials.

As an international company based in the US and Canada, Serenus Global Inc. is dedicated to enhancing the well-being of people around the world through the educated use of controlled substances.

To learn more about Serenus Global Inc., or investment opportunities, please visit http://www.serenus.global.

About Serenus Global Inc.:

Serenus Global is one of the world’s first multi-disciplinary controlled substances companies. Serenus is dedicated to the production and supply of consistent and compliant materials for medical and adult-use markets, and enhancing well being through the educated use of controlled substances. As new markets emerge, and research and medical developments expand, Serenus is committed to being a trusted team recognized for advancing industry development.

Share article on social media or email:

Brain Metastases – Challenges of Developing Clinically Relevant Preclinical Models, Upcoming Webinar Hosted by Xtalks


Several key modulators in the hostile brain tumor microenvironment promote cancer cell proliferation, apoptosis, metabolism, growth factor signaling, migration and invasion. There is a growing need to understand brain metastases.

The metastasis of certain systemic cancers to the brain poses a significant challenge to oncologists and patients alike. Several key modulators in the hostile brain tumor microenvironment promote cancer cell proliferation, apoptosis, metabolism, growth factor signaling, migration and invasion. There is a growing need to understand brain metastases.

The complexity of the blood-brain barrier (BBB) and lack of effective targeted drugs that penetrate BBB is the greatest challenge in treating brain metastases. Consequently, many researchers are experimenting with various in vitro and in vivo models of brain metastases to better understand how these cancers migrate to the brain, and what type of therapeutic molecules penetrate the BBB to reach brain tumor cells.

In this webinar, the featured speaker discusses few of these preclinical models that might impact the clinical development of metastatic brain tumor-specific anticancer drugs.

Join this webinar to learn about the challenges for developing clinically relevant preclinical models for brain cancer.

Join Dr. Nagendra Ningaraj, Global Senior Director of Scientific Affairs, Aragen Life Sciences, USA, for the live webinar on Thursday, August 25, 2022, at 11am EDT (4pm BST/UK).

For more information, or to register for this event, visit Brain Metastases – Challenges of Developing Clinically Relevant Preclinical Models.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

Preparing and Aligning Your Biotech Organization for Commercial Success, Upcoming Webinar Hosted by Xtalks


As emerging biotech companies find the right path to commercialization for their organization, there are key questions to consider when determining if your organization is aligned for commercial success

An emerging biotech company clearly relies on its scientific prowess to develop an asset that can be efficacious. Throughout development, this scientific “weight” is valuable but too often, promising science is unable to overcome underfunded and under-planned commercial strategy. As emerging biotech companies find the right path to commercialization for their organization, there are key questions to consider when determining if your organization is aligned for commercial success, including:


  • Are company goals achievable when transitioning to a commercial organization?
  • Is the organization making the right decisions regarding commercial investment?
  • Is the Board and C-suite able to lead the organization to a commercial mindset?
  • Applying a commercial lens from the outset can help companies stay on course and enhance commercial viability.

Register for this webinar to learn more about preparing and aligning your company for commercial success.

Join Lee Taurman, SVP, Full-Service Commercial, Syneos Health®; John Dillman, Chief Commercial Officer, VBI Vaccines; and Brian Johnson, Chief Commercial Officer, Novan, for the live webinar on Friday, August 26, 2022, at 10am EDT (3pm BST/UK).

For more information, or to register for this event, visit Preparing and Aligning Your Biotech Organization for Commercial Success.

ABOUT SYNEOS HEALTH

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success. We lead with a product development mindset, strategically blending clinical development, medical affairs, and commercial capabilities to address modern market realities.

To learn more about how we are Shortening the distance from lab to life®, visit syneoshealth.com or subscribe to our podcast.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

W. David Ellrich, Founder of Leading Forensic Accounting Firm, Retires


W. David Ellrich, Founder of Florida's Leading Forensic Accounting Firm

W. David Ellrich, Founder of Florida’s Leading Forensic Accounting Firm

Dave embodies what it means to pursue passions and do truly great work with integrity and credibility each step of the way.

Ellrich, Neal, Smith & Stohlman, P.A., one of the leading forensic accounting firms in South Florida, announced the recent retirement of its leader, W. David “Dave” Ellrich, CPA, CFE, CVA, ABV, MAFF, ASA, CFF. Dave helped shaped the litigation and forensic accounting industry as trailblazer in the 1980’s, cultivating a standard for success for all who followed his storied career.

Dave worked on some of the biggest and most interesting litigation cases and divorces, with some of the most notable lawyers in the country. His ability to communicate financial issues in a case to the trier of fact was superior to anyone else in the industry. He was an arbitrator, an IRS instructor, led Practicing CPA seminars, served as an expert witness in Federal District Court and State Circuit Court, and a member of the American Institute of Certified Public Accountants, Florida Institute of Certified Public Accountants, American Society of Appraisers, Association of Certified Fraud Examiners, and the National Association of Certified Valuation Analysts. Dave’s road to success was paved by unmatched expertise, hard work, and a passion for forensic accounting with integrity.

Dave graduated Florida State University in 1973 with a degree in accounting and continued his education with a Masters in Accounting. He also completed advanced training in Financial Investigative Techniques as well as law enforcement related areas through the Federal Law Enforcement Training Center. He worked for the Internal Revenue Service (IRS) as an Internal Revenue Agent in the U.S. Treasury from 1974 to 1978.

Ellrich & Co., CPAs, currently Ellrich, Neal, Smith & Stohlman, P.A., was founded by Dave in 1981, eventually merging the company with his wife in 1988. He led the organization for 40 years, creating one of the most sought-after, prominent forensic accounting firms in the state.

Dave is a husband, a father, and a grandfather. He still serves as a mentor for everyone at Ellrich, Neal, Smith & Stohlman, P.A., embodying what it means to pursue passions and do truly great work with integrity and credibility each step of the way.

Matthew C. Smith, Co-Managing Shareholder at Ellrich, Neal, Smith & Stohlman remarked, “Dave’s the best. He took a chance on me, just a college kid that enjoyed the same activities that he did. We both played D1 sports, and loved to fish, hunt and enjoyed the outdoors… and he trained me, and all of us really, on the importance of integrity and credibility in the work we do. He was tough, but fair. And in the end, I love to wake up every morning and come to the office to get to do this type of work. And I have him to thank for that!”

About Ellrich, Neal, Smith & Stohlman, P.A.

Ellrich, Neal, Smith & Stohlman, P.A. is committed to providing high-quality financial, tax and forensic accounting services throughout the state of Florida. With locations in Palm Beach Gardens, Miami, and Orlando, the firm’s litigation services department provides professional services to participants in the legal process. These services include forensic accounting, fraud detection and prevention, assistance with discovery matters, consultation, and expert witness testimony.

In addition, the firm provides business valuation services as their trained valuation analysts have the qualifications and experience to value a business for a variety of purposes, including the purchase or sale of a business, divorce of an owner, estate and gift matters, business and contractual disputes, eminent domain condemnations, and to assist in financing. For more information, please visit: https://ensscpa.com/.

Share article on social media or email:

Digital Silk & Evlo Fitness Launch A Vibrant New Digital Experience to Grow the Fitness Brand Online


Fitness brand website by Digital Silk

Evlo Fitness’ new website is live

“This is what makes a brand feel authentic; a brand that is true to its founder’s personality and company culture will feel true to its audience.” – Boban Vaiagich, Director of Brand Design at Digital Silk

Founded by a renowned physical therapist Dr. Shannon Ritchey, fitness brand Evlo partnered with a creative digital agency Digital Silk to reimagine and grow their online presence through strategic branding and web design.

Evlo competes in a highly saturated market of online fitness programs. To stand out, the brand needed an authentic, visually distinctive look and feel, as well as effective, clear, and unique value proposition (UVP) driven messaging. Digital Silk’s Director of Brand Strategy Courtney Bozigian and her team of brand strategy experts led a series of structured discovery exercises to define Evlo’s core messaging to leverage in all brand communications, as well as their brand visual design.

“Thanks to industry research, competitive analysis and brand positioning exercises, we were able to clearly identify what makes Evlo unique, and create a positioning that is unique ownable to them,” said Bozigian. “These insights translated into the key messaging territories that would underpin all brand communications, including website and marketing copy and the brand visual identity .”

The agency focused on Evlo’s unique methodology of effective workouts that are safe and gentle for your joints, developed and delivered by “doctors of physical therapy and highly trained fitness instructors” as one of the key differentiators.

Having defined Evlo’s brand strategy, Digital Silk reimagined the brand’s visual identity. Lead by Director of Brand Design Boban Vaiagich, the agency’s brand designers crafted a vibrant brand book, complete with their new color palette, typography, imagery, iconography and other visual resources that would maintain consistency in Evlo’s presentation.

“We used lots of dynamic elements such as rhomboids, diagonally stacked lines and italicized text coupled with a youthful and soft color palette to communicate both the energy and strength this program promotes, and the gentle nature of its approach,” explained Vaiagich.

According to Vaiagich, Evlos’ visual identity was inspired by both its new brand strategy and its leadership, particularly Dr. Ritchey.

“In the brand design phase, we were heavily focused on capturing not only what Evlo’s audience expects and responds to, but also Dr. Ritchey and her team’s unique brand culture,” said Vaiagich. “This is what makes a brand feel authentic; a brand that is true to its founder’s personality and company culture will feel true to its audience.”

Evlo’s visual identity then took form in their new website design. Under the leadership of Vice President Keith Solomon, Digital Silk’s web design experts developed the brand’s digital strategy which formed a blueprint for their website structure, messaging, and design.

“Evlo’s web design is the embodiment of their brand strategy guided by a digital strategy,” said Solomon. “Each landing page follows user experience (UX) design best practices and is fully optimized for marketing campaigns which is key to their future online growth.”

Digital Silk and Evlo Fitness recently launched the brand’s new website, introducing the redesigned identity to their loyal online community as well as prospect audiences.

About Digital Silk:

Digital Silk is a creative digital agency focused on growing brands online. From custom websites to digital marketing, Digital Silk creates SUPERIOR digital experiences to drive higher conversions, greater brand engagement and measurable results.

Share article on social media or email:

PAINWeek 2022 Announces the Return of the ASIPP and Interventional Pain Management Tracks


The PAINWeek National Conference, September 6-9

“PAINWeek has always been one of my favorite meetings because of its diversity and inclusion: it is the only meeting where I can join clinicians from all specialties who treat pain patients.”

The statistics are alarming: At least a fifth of the US population has chronic pain.[1] Costs to society, ranging from direct costs to lost work, is over $630 billion a year.[2] Something needs to change, and education will help. At the PAINWeek National Conference, September 6-9 at The Cosmopolitan of Las Vegas, attendees will experience stellar pain management education, including the ASIPP—American Society of Interventional Pain Physicians—and the Interventional Pain Management Tracks.

The ASIPP Track will include Nick Knezevic, MD, PhD, presenting Atomic Secrets: Regenerative Medicine in Managing Chronic Pain. He commented, “ASIPP has a long-standing relationship with PAINWeek. Together, they’ve organized a series of lectures with ASIPP key leaders as speakers to help explain the importance of interventional pain management procedures in managing pain conditions.”

The ASIPP Track will also feature the following courses and presenters:

  • The Tingler: Evidence Based Minimally Invasive Interventions for Chronic Low Back Pain (Kiran Patel, MD)
  • Breakfast of Champions: Ketamine Infusion for Chronic Pain and Depression (Kiran Patel, MD)
  • The Skeleton Key: Failed Back Surgery Syndrome and Spinal Cord Stimulation (Mayank Gupta, MD)
  • Management of Chronic Abdominal Pain: Treatment Algorithm (Alaa Abd-Elsayed, MD, MPH, FASA)

Sean Li, MD, who will present during the Interventional Pain Management Track, stated, “PAINWeek has always been one of my favorite meetings because of its diversity and inclusion: it is the only meeting where I can join clinicians from all specialties who treat pain patients.” Dr. Li’s sessions: The Petrified Forest: Sacroiliac Joint Dysfunction and Treatment Update; and When Stars Align: The New Era of Peripheral Nerve Stimulation. He continued, “Attendees will experience an emersion of emotional and intellectual experiences into the world of pain management. Don’t miss out!”

Johnathan Goree, MD, who will co-present East v. West: Who Should Hold the Needle First?, commented, “I am excited to again take part in PAINWeek, this time discussing back pain and ‘What’s next?’ I will debate Carrie Hyde, MD, a physician medical acupuncturist, and discuss our approaches to the low back pain patient, treatment philosophies, cost benefit analysis. Who’ll win the debate? Both attendees and patients!”

The Interventional Pain Management Track will also feature:

  • Landscape of Wonders: Injections, Nerve Blocks, Pumps, and Neuromodulation (Paul Christo, MD, MBA)
  • The Lowdown: Rethinking the Role of Interventional Pain Management (Michael Bottros, MD)

PAINWeek will present over 75 CME/CE credit hours in tracks such as Behavioral Pain Management, Chronic Pain Syndromes, Health Coaching, Integrative Pain Management, Medical/Legal, Neurology, Physical Therapy, Pharmacotherapy, and Psychedelics. Master Classes, Special Interest Sessions, and sponsored courses complement the agenda, along with tracks presented by the International Pelvic Pain Society.

For more information, click PAINWeek or go to painweek.org.

Dr. Goree: Associate Professor and Director of Chronic Pain Division, University of Arkansas for Medical Sciences, Little Rock. Dr. Knezevic: Clinical Professor of Anesthesiology & Surgery, College of Medicine, University of Illinois, Chicago. Dr. Li: Regional Medical Director, National Spine and Pain Centers, Lincroft, New Jersey.

PAINWeek accreditation provided by Global Education Group:

Global Education Group focuses on producing partnership-based CME for healthcare practitioners. The Global team works with a select group of medical education companies, associations, academic institutions, and healthcare facilities to develop and accredit live healthcare conferences and workshops as well as online activities. With each partnership or joint providership, Global brings accreditation expertise, project management excellence and grant funding intelligence. Based in Littleton, Colo., Global has accreditation with commendation from the ACCME and accredited with distinction from the ANCC. Global also holds accreditations to offer continuing education for nurse practitioners, pharmacists, dietitians, dentists, and psychologists. Global is a division of Ultimate Medical Academy.

1. National Center for Health Statistics, National Health Interview Survey, 2019.

2. https://nationalpain.org/fast-facts-about-pain

###

Share article on social media or email:

JumpstartMD Partners With OK Capsule To Fight Obesity Epidemic Through Personalization, Convenience, Service, and Technology


JumpStartMD

Knowing that by 2030, 50% of the US population will be considered obese and 42% of U.S. adults reported gaining an average of 29 pounds during the pandemic, JumpstartMD is on a mission to help those struggling with excess weight and associated health conditions lead a healthier, happier life.

JumpstartMD has partnered with OK Capsule to make the process of personalizing and delivering weight loss supplements more seamless and effective than ever before. As of July 25th, OK Capsule is able to manufacture for JumpstartMD the safest and most effective weight loss and wellness supplements with a focus on customized formulary, personalization, convenience, service, and technology to make significant progress in helping individuals lose weight. This partnership allows JumpstartMD, which has already helped its members lose over 1,000,000 lbs. through their proven medically supervised weight loss program, to further personalize their offerings.

Here’s how: OK Capsule, founded by Dr. Andrew Brandeis, a physician with over ten years of experience practicing integrative medicine, has disrupted the supplement industry by empowering its partners to scale the delivery of personalized, premium-grade supplement packets to their customers.

JumpstartMD is the largest medical weight loss and wellness practice in Northern California helping thousands of people lose weight through science, natural food and lifestyle changes. They transform lives through one-on-one health coaching, lifestyle changes, guidance on real food consumption and weight loss medication. Focused on sustainable healthy lifestyles rather than crash diets or rigid programs, JumpstartMD offers Weight Loss, Bioidentical Hormone Therapy, Vitamin Therapy and now five different personalized Supplement Packs to help their members on their weight loss and wellness journey. As sourcing, true customization and especially compliance can be challenging in the supplement industry, OK Capsule provides the technology platform to deliver the Supplement Packs to members’ doorsteps once per month, allowing them to reorder seamlessly.

One of the drivers for the creation of OK Capsule was that Dr. Brandeis found compliance to be the most challenging part with his patients, including himself. “I can tell you that very few people will open 4 to 5 bottles per day, even a couple of times per day, to take their supplements,” says Brandeis. “Rather than opening 2–3 bottles, which is very cumbersome, with compostable packs, you can keep a couple of packs at your desk or in your purse or when you travel, and when you need them, you have the solution there when you need it.” This solution to compliance alone has already redefined the medical industry through environmental single-serve packaging (no bottles!) and ease. OK Capsule’s compostable “take it anywhere” packages have helped people live healthier and happier lives, because they are consistent with their program. Additionally, each order of the compostable packets saves 200 grams of plastic bottles from ending up as trash.

“Knowing that by 2030, it’s predicted that 50% of the US population will be considered obese and that, per a survey from the American Psychological Association, 42% of U.S. adults reported gaining an average of 29 pounds during the pandemic, JumpstartMD is on a mission to help those struggling with excess weight and associated health conditions lead a healthier, happier life,” said Parham Javaherian, CEO of JumpstartMD. In addition to recommending real food, providing individualized support from our team of experts, and using a scientifically proven approach, JumpstartMD differs from many competitors in additionally being able to prescribe FDA approved medications to support and sustain superior weight losses, including two recently approved FDA medications remarkably effective at weight loss, among other positive benefits.”

These two new FDA approved medications include Wegovy® (semaglutide) and Mounjaro® (terzepatide), the former showing weight loss outcomes of 15% to 17% at 64 weeks and the latter publishing data in July showing nearly 21% average weight loss (over 50 pounds) at 72 weeks. Interestingly, JumpstartMD published its own outcomes on over 22,000 patients in The Journal of Obesity in 2020 (prior to the release of the two above mentioned medications) and showed similarly effective results in an even shorter time span and with or without medication support (the outcomes were superior to all commercial brands including Weight Watchers). Regardless, all of those outcomes create clinically meaningful and life-transforming results not only in the short term but in the long-run to the extent that medication support can also prevent weight regain after major losses. Such new therapies create a unique competitive advantage to continue to deliver and sustain superior outcomes in medically supervised weight loss organizations like JumpstartMD, given the fact that well-known competitors such as Weight Watchers and Noom are unable to offer medication support.

Javaherian adds “OK Capsule’s partnership with JumpstartMD creates another opportunity to prescribe tailored supplements to drive superior results to Jumpstart our members’ health and well-being through a system that creates a convenient, personalized, and high touch experience by leveraging advanced technology in combination with the highest-quality supplements.”

ABOUT JUMPSTARTMD

JumpstartMD is a personalized science-based Weight Management Program driven by Stanford-trained physicians and Diplomates of the American Board of Obesity and it is the largest medical weight loss practice in Northern California. Medically supervised and based on extensive clinical research, JumpstartMD is centered on nutritional science and one-on-one support making a real difference. JumpstartMD provides services including Weight Loss, Bioidentical Hormone Replacement Therapy, Vitamin Therapy and Supplement Therapy. For more info, visit: http://www.jumpstartmd.com

ABOUT OK CAPSULE

OK Capsule provides the technology, products, fulfillment, and strategic support that makes it safe, simple, and sustainable for businesses to launch and scale the delivery of tailored supplement packets to their customers. OK Capsule’s enterprise platform is the foremost solution for companies and brands to formulate, sell, and deliver personalized nutrition at any scale. For more info, visit http://www.okcapsule.com

Share article on social media or email:

Rotarian, Thrill-Seeker Completes Fourth Solo Cross-Country Bicycle Trek to End Polio. More than 10,000 miles to End Polio Now sponsored by Air Animal Pet Movers


Nick Hall heading to the Pacific in San Diego for the traditional end-of-ride tire dip.

Nick Hall heading to the Pacific in San Diego for the traditional end-of-ride tire dip.

The global pandemic shut down polio vaccination programs allowing wild polio virus to spread. Hall believes ending polio is within reach for all humankind.

Nick Hall, a 74-year-old Rotarian, retired psychoneuroimmunologist and motivational speaker, has finished his fourth cross-country bicycle trip dipping his bicycle tire in the Pacific at Oceanside, CA. The Seattle to San Diego route along the Pacific Coast Highway and US 101 “boxed in the U.S.” along the West Coast. Hall rode solo without a support van and was sponsored by Air Animal Pet Movers.

Hall’s rides have all raised funds for Rotary International’s efforts to end polio in the world. He’s been a self-described thrill seeker since childhood. In the 1960s, Hall wrestled alligators as a summer job in Black Hills, SD before pedaling his bicycle to Massachusetts for the fall semester.

Nick’s 2015 Pedal Power to End Polio Now excursion began in San Diego and ended in St. Augustine, FL. In 2018 Hall rode from Temple Terrace, FL to the Rotary International Convention in Toronto, Canada. The Seattle to Tampa ride in 2020 challenged Hall with mountain ranges and COVID shutdowns. Can you imagine pedaling all day in summer heat and finding restaurants, gas stations and parks closed? Together, the trips raised $50,400 to end polio.

“My goal this year is to get as many $10K donations as possible from individuals and Rotary clubs marking the fact that this trip will put me over the 10,000 mile mark since that first ride in 2015,” Hall said.

Air Animal Pet Movers, owned by fellow Rotarian Walter M. Woolf, VMD, is the ride’s major sponsor.“Nick’s tenacity and physical capabilities amaze and entertain at the same time as he’s helping Rotary reach our goal of a polio-free world. The world beat smallpox. We can win against polio by working together—especially with the worldwide COVID endemic,” Woolf said.

The lead $10,000 donation came from Thomas Dempsey and Alexis Dempsey Doyle. “Dr. Nick Hall inspires us all to push to our greatest and furthest extent! His commitment to ending polio now inspires our donation,” said Alexis. All donations to the ride through the 501(C)3 Rotary District 6890 Foundation will be sent to the Rotary International Foundation Polio Plus campaign.

The global pandemic shut down polio vaccination programs allowing wild polio virus to spread. From a low of 22 cases two countries in 2017 to 140 cases in 2020. Hall believes ending polio is within reach for all humankind. He vividly remembers polio epidemics of his youth when public pools were closed to prevent spreading the virus.

See our blog for links to “What the Polio Case in New York Tells Us About the End of Polio” by Arthur Allen, Kaiser Health News, July 29, 2022 and to donation information. Every donation will be matched by the Gates Foundation.

Share article on social media or email: